Cancer Research

Gene Fusion Detection and Characterization in Long-Read Cancer Transcriptome Sequencing Data with FusionSeeker.  83:28-33. 2023

Retraction: CXCR6 Induces Prostate Cancer Progression by the AKT/Mammalian Target of Rapamycin Signaling Pathway (Cancer Research (2022) 82 (3406) DOI: 10.1158/0008-5472.CAN-08-2780).  82:3406. 2022

Retraction: Characterization of Phosphoglycerate Kinase-1 Expression of Stromal Cells Derived from Tumor Microenvironment in Prostate Cancer Progression (Cancer Research (2022) 82 (3405) DOI: 10.1158/0008-5472.CAN-09-2863).  82:3405. 2022

Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic Resistance.  82:2344-2353. 2022

Understanding Drug Sensitivity and Tackling Resistance in Cancer.  82:1448-1460. 2022

Correction: PHGDH expression is required for mitochondrial redox homeostasis, breast cancer stem cell maintenance, and lung metastasis (Cancer Research (2016) 76 (4430-4442) DOI: 10.1158/0008-5472.CAN-16-0530).  82:1153. 2022

Abstract P2-12-24: Exosomal metabolic signatures are associated with differential response to neoadjuvant chemotherapy in patients with breast cancer.  82:p2-12-24-p2-12-24. 2022

Abstract P3-09-14: Whole exome sequencing of matched primary and metastatic triple-negative breast cancer samples.  82:p3-09-14-p3-09-14. 2022

Abstract P5-07-01: Proteogenomic analysis of differential chemotherapy responses in patient-derived xenografts of triple-negative breast cancer.  82:p5-07-01-p5-07-01. 2022

Abstract IA-003: Proteogenomic characterizations of pancreatic ductal adenocarcinoma.  81:ia-003-ia-003. 2021

Epigenetic alterations and mechanisms that drive resistance to targeted cancer therapies.  81:5589-5595. 2021

Erratum: CXCL12γ promotes metastatic castration-resistant prostate cancer by inducing cancer stem cell and neuroendocrine phenotypes (Cancer Research (2018) 78 (2026–2039) DOI: 10.1158/0008-5472.CAN-17-2332).  81:5777. 2021

Hedgehog signaling regulates metabolism and polarization of mammary tumor-associated macrophages.  81:5425-5437. 2021

STAT3 and GR cooperate to drive gene expression and growth of basal-like triple-negative breast cancer.  80:4355-4370. 2021

The inhibitor of apoptosis protein livin confers resistance to fas-mediated immune cytotoxicity in refractory lymphoma.  80:4439-4450. 2021

TET2 and DNMT3A Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP Inhibitors..  81:5089-5101. 2021

Gut microbiota–derived short-chain fatty acids promote prostate cancer growth via IGF1 signaling.  81:4014-4026. 2021

Abstract 1747: Oncolytic Vesicular Stomatitis Virus expressing a species relevant interferon-beta is safe and provides a survival benefit when added as neoadjuvant to the standard of care for dogs with naturally occurring bone cancer.  81:1747-1747. 2021

Abstract 2992: Proteogenomic characterization of triple-negative breast cancer patient-derived xenografts reveals molecular correlates of differential chemotherapy response and potential therapeutic targets to overcome resistance.  81:2992-2992. 2021

Abstract 671: Development of an exosomal biomarker signature to detect minimal residual disease in dogs with osteosarcoma using a novel xenograft platform and machine learning.  81:671-671. 2021

Abstract LB245: TRIM29 mediates metastasis though hypoxia-regulated proteins in microsatellite-stable and p53-mutated colorectal cancers.  81:lb245-lb245. 2021

Erratum: Mitochondrial dna repair through ogg1 activity attenuates breast cancer progression and metastasis (Cancer Research (2016) 76 (30-34) DOI: 10.1158/0008-5472.CAN-15-0692).  81:3144. 2021

Targeting the HuR oncogenic role with a new class of cytoplasmic dimerization inhibitors.  81:2220-2233. 2021

miR-31 displays subtype specificity in lung cancer.  81:1942-1953. 2021

Retraction: A glycolytic mechanism regulating an angiogenic switch in prostate cancer (Cancer Research (2007) 67 (149-159) DOI: 10.1158/0008-5472.CAN-06-2971).  81:1623. 2021

Stromal Platelet–Derived Growth Factor Receptor-b Signaling Promotes Breast Cancer Metastasis in the Brain.  81:606-618. 2021

EZH2-targeted therapies in cancer: Hype or a reality.  80:5449-5458. 2020

Abstract 2012: Recurrent rearrangements of NAALADL2 in prostate, breast, cervical, head and neck and lung squamous cell carcinoma.  80:2012-2012. 2020

Abstract 5655: Efficacy of antibodies targeting TfR1 in xenograft mouse models of AIDS-related non-Hodgkin lymphoma.  80:5655-5655. 2020

P38g MAPK Is essential for aerobic glycolysis and pancreatic tumorigenesis.  80:3251-3264. 2020

Long noncoding RNA DRAIC inhibits prostate cancer progression by interacting with IKK to inhibit NF-κB activation.  80:950-963. 2020

Runx2 deficiency in osteoblasts promotes myeloma progression by altering the bone microenvironment at new bone sites.  80:1036-1048. 2020

Abstract GS2-05: Microscaled proteogenomic methods for precision oncology.  80:gs2-05-gs2-05. 2020

Heparanase and chemotherapy synergize to drive macrophage activation and enhance tumor growth.  80:57-68. 2020

The role of metabolic plasticity in blood and brain stem cell pathophysiology.  80:5-16. 2020

Targeting glycolysis through inhibition of lactate dehydrogenase impairs tumor growth in preclinical models of Ewing sarcoma.  79:5060-5073. 2019

The tumor microenvironment innately modulates cancer progression.  79:4557-4567. 2019

Chromosome 12p amplification in triple-negative/BRCA1-mutated breast cancer associates with emergence of docetaxel resistance and carboplatin sensitivity.  79:4258-4270. 2019

Metabolic reprogramming by MYCN confers dependence on the serine-glycine-one-carbon biosynthetic pathway.  79:3837-3850. 2019

Abstract 1021: CD24 dependent inactivation of mutant p53 in metastatic castration resistant prostate cancer.  79:1021-1021. 2019

Abstract 2481: Developing analysis platform for pan-cancer study of DNA methylation, mirna and lncrna expression based on tumor subtypes using TCGA data.  79:2481-2481. 2019

Abstract 5247: Overexpression of methylenetetrahydrofolate dehydrogenase 1 like (MTHFD1L) in bladder cancer: A potential therapeutic target.  79:5247-5247. 2019

Abstract 851: MicroRNA-124 modulated collagen-prolyl hydroxylase P4HA1 expression regulates colon cancer progression.  79:851-851. 2019

Abstract CT233: Treatment of neurofibromatosis type 1 (NF1)-related plexiform neurofibromas (PN) with cabozantinib (XL184): A Neurofibromatosis Clinical Trials Consortium Phase II trial.  79:ct233-ct233. 2019

Abstract LB-247: 9cis-retinoic UAB30 inhibits UVB-induced pro-inflammatory cytokines/chemokines signaling via targeting Bromodomain-4.  79:lb-247-lb-247. 2019

Defining the Hallmarks of Metastasis.  79:3011-3027. 2019

Spleen tyrosine kinase–mediated autophagy is required for epithelial–mesenchymal plasticity and metastasis in breast cancer.  79:1831-1843. 2019

A model system for studying the DNMT3A HOTSPO mutation (DNMT3A^R882) demonstrates a causal relationship between its dominant-negative effect and leukemogenesis.  79:3583-3594. 2019

Loss of FOXP3 and TSC1 accelerates prostate cancer progression through synergistic transcriptional and posttranslational regulation of c-Myc.  79:1413-1425. 2019

CDK8 selectively promotes the growth of colon cancer metastases in the liver by regulating gene expression of TIMP3 and matrix metalloproteinases.  78:6594-6606. 2018

Retraction: (–)-epigallocatechin-3-gallate prevents photocarcinogenesis in mice through interleukin-12–dependent DNA repair (Cancer Research (2006) 66 (5512–5520) DOI: 10.1158/0008-5472.CAN-06-0218).  78:6709. 2018

Retraction: Interleukin-12 deficiency is permissive for angiogenesis in UV radiation-induced skin tumors (Cancer Research (2007) 67 (3785–3793) DOI: 10.1158/0008-5472.CAN-06-3134).  78:6708. 2018

Discovery and characterization of dual inhibitors of MDM2 and NFAT1 for pancreatic cancer therapy.  78:5656-5667. 2018

Determination of tumor margins with surgical specimen mapping using near-infrared fluorescence.  78:5144-5154. 2018

Pathology, chemoprevention, and preclinical models for target validation in Barrett esophagus.  78:3747-3754. 2018

Abstract 3141: Immune gene expression and prognosis in localized clear cell (cc) renal cell carcinoma (RCC).  78:3141-3141. 2018

Abstract 3495: Trip13, a target of miR192, facilitates colorectal cancer progression through WNT/β-catenin signaling.  78:3495-3495. 2018

Abstract 4043: A novel role for Hedgehog signaling in macrophage-mediated immune evasion.  78:4043-4043. 2018

Abstract 4483: Functional implications of PRDM16 loss in kidney cancer.  78:4483-4483. 2018

Abstract 5482: L-2HG/ L2HGDH axis as therapeutic target for kidney cancer.  78:5482-5482. 2018

Activation of the receptor tyrosine kinase AXL regulates the immune microenvironment in glioblastoma.  78:3002-3013. 2018

Inhibin is a novel paracrine factor for tumor angiogenesis and metastasis.  78:2978-2989. 2018

CXCL12g promotes metastatic castration-resistant prostate cancer by inducing cancer stem cell and neuroendocrine phenotypes.  78:2026-2039. 2018

Abstract P3-04-01: Molecular determinants of post-mastectomy breast cancer recurrence.  78:p3-04-01-p3-04-01. 2018

YAP1 and COX2 coordinately regulate urothelial cancer stem-like cells.  78:168-181. 2018

Mitochondrial haplotype alters mammary cancer tumorigenicity and metastasis in an oncogenic driver–dependent manner.  77:6941-6949. 2017

Mitochondrial genomic backgrounds affect nuclear DNA methylation and gene expression.  77:6202-6214. 2017

STRAP promotes stemness of human colorectal cancer via epigenetic regulation of the NOTCH pathwaya.  77:5464-5478. 2017

Abstract 475: Role of microRNA-34a in regulating oncoprotein STMN1.  77:475-475. 2017

Abstract 5287: Recent trends in racial and regional disparities in cervical cancer incidence and mortality.  77:5287-5287. 2017

Regulatory aspects of optical methods and exogenous targets for cancer detection.  77:2197-2206. 2017

Bone metastasis of prostate cancer can be therapeutically targeted at the TBX2-WNT signaling axis.  77:1331-1344. 2017

Mutational landscape and gene expression patterns in adult acute myeloid Leukemias with Monosomy 7 as a sole abnormality.  77:207-218. 2017

Abstract A21: Chemokine directed migration of activated stellate cells in pancreatic ductal adenocarcinoma.  76:a21-a21. 2016

Syndecan-1 (CD138) suppresses apoptosis in multiple myeloma by activating IGF1 receptor: Prevention by synstatinIGF1R inhibits tumor growth.  76:4981-4993. 2016

PHGDH expression is required for mitochondrial redox homeostasis, breast cancer stem cell maintenance, and lung metastasis.  76:4430-4442. 2016

Abstract 3861: Ruxolitinib inhibits STAT-3 activation in glioblastoma.  76:3861-3861. 2016

The tumor-associated glycosyltransferase ST6Gal-I regulates stem cell transcription factors and confers a cancer stem cell phenotype.  76:3978-3988. 2016

Tumor cell invasion-not all barriers are created equal.  76:1675-1676. 2016

Mitochondrial DNA repair through OGG1 activity attenuates breast cancer progression and metastasis.  76:30-34. 2016

Tumor heterogeneity - A 'contemporary concept' founded on historical insights and predictions.  76:4-6. 2016

Essential components of cancer education.  75:5202-5205. 2015

Identification of variant-specific functions of PIK3CA by rapid phenotyping of rare mutations.  75:5341-5354. 2015

Androgen-regulated SPARCL1 in the tumor microenvironment inhibits metastatic progression.  75:4322-4334. 2015

Mitochondrial genetics regulate breast cancer Tumorigenicity and Metastatic potential.  75:4429-4436. 2015

KAP1 promotes proliferation and metastatic progression of breast cancer cells.  75:344-355. 2015

Abstract 2776: Codon 72 and Intron-3 polymorphisms in TP53 are risk factors for breast cancer.  2776-2776. 2015

Abstract 4004: Prognostic value of miRNAs in breast cancer varies with patient race and molecular subtype.  4004-4004. 2015

Abstract 4953: Molecular and cellular localization profiles of tristetraprolin in colorectal cancer: Implications for tumor progression in diverse patient populations.  4953-4953. 2015

Abstract P1-09-07: Patient centered support in the survivorship care transition: Outcomes from the patient-owned survivorship care plan intervention.  p1-09-07-p1-09-07. 2015

FOXP3 controls an MIR-146/NF-κB negative feedback loop that inhibits apoptosis in breast cancer cells.  75:1703-1713. 2015

FOXP3-MIR-146-NF-κB axis and therapy for precancerous lesions in prostate.  75:1714-1724. 2015

IGF2 preserves osteosarcoma cell survival by creating an autophagic state of dormancy that protects cells against chemotherapeutic stress.  74:6531-6541. 2014

SCCA1/SERPINB3 promotes oncogenesis and epithelial-mesenchymal transition via the unfolded protein response and IL6 signaling.  74:6318-6329. 2014

β-catenin contributes to lung tumor development induced by EGFR mutations.  74:5891-5902. 2014

Abstract 3820: Expression of ST6Gal-1 in colorectal cancer and patient prognosis.  3820-3820. 2014

Abstract LB-131: Elevated (L) -2-hydroxyglutarate promotes loss of 5-hydroxymethylcytosine in clear cell renal cancer.  lb-131-lb-131. 2014

Sonic hedgehog signaling in basal cell nevus syndrome.  74:4967-4975. 2014

Human brat ortholog TRIM3 is a tumor suppressor that regulates asymmetric cell division in glioblastoma.  74:4536-4548. 2014

Neuroplastic changes occur early in the development of pancreatic ductal adenocarcinoma.  74:1718-1727. 2014

P14ARF suppresses tumor-induced thrombosis by regulating the tissue factor pathway.  74:1371-1378. 2014

Metastasis suppressor KISS1Seemsto reverse the warburg effect by enhancing mitochondrial biogenesis.  74:954-963. 2014

FGFR1-WNT-TGF-β signaling in prostate cancer mouse models recapitulates human reactive stroma.  74:609-620. 2014

TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine.  73:7162-7167. 2013

Enhancement of antitumor immunity in lung cancer by targeting myeloid-derived suppressor cell pathways.  73:6609-6620. 2013

Adenomatous polyps are drivenbymicrobe-instigated focal inflammation and are controlled by IL-10-producing T cells.  73:5905-5913. 2013

Aptamer identification of brain tumor-initiating cells.  73:4923-4936. 2013

Myeloid-derived suppressor cells as osteoclast progenitors: A novel target for controlling osteolytic bone metastasis.  73:4606-4610. 2013

4-hydroxytamoxifen induces autophagic death through K-Ras degradation.  73:4395-4405. 2013

Abstract 1944: Evaluation of the prognostic value of miRNA-181b and its target identification and validation in colorectal cancers..  73:1944-1944. 2013

FOXP3 regulates sensitivity of cancer cells to irradiation by transcriptional repression of BRCA1.  73:2170-2180. 2013

ST6Gal-I protein expression is upregulated in human epithelial tumors and correlates with stem cell markers in normal tissues and colon cancer cell lines.  73:2368-2378. 2013

Dysregulation of cholesterol homeostasis in human prostate cancer through loss of ABCA1.  73:1211-1218. 2013

Myeloid-derived suppressor cells function as novel osteoclast progenitors enhancing bone loss in breast cancer.  73:672-682. 2013

Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.  72:6425-6434. 2012

Targeting BRCA1 localization to augment breast tumor sensitivity to poly(ADP-Ribose) polymerase inhibition.  72:5547-5555. 2012

RAP80 is critical in maintaining genomic stability and suppressing tumor development.  72:5080-5090. 2012

HER2 overexpression renders human breast cancers sensitive to PARP inhibition independently of any defect in homologous recombination DNA repair.  72:4796-4806. 2012

Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death.  72:2634-2644. 2012

Abstract 1210: Tetraspanin CD63 interacts with extranuclear estrogen receptor alpha and regulates non-genomic signaling pathways in breast cancer.  72:1210-1210. 2012

Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape.  72:917-927. 2012

HMGB1 promotes drug resistance in osteosarcoma.  72:230-238. 2012

Metastasis suppressor NM23-H1 promotes repair of UV-induced DNA damage and suppresses UV-induced melanomagenesis.  72:133-143. 2012

Overexpression of MBD2 in glioblastoma maintains epigenetic silencing and inhibits the antiangiogenic function of the tumor suppressor gene BAI.  71:5859-5870. 2011

TMPRSS2-ERG-mediated feed-forward regulation of wild-type ERG in human prostate cancers.  71:5387-5392. 2011

p53-dependent BRCA1 nuclear export controls cellular susceptibility to DNA damage.  71:5546-5557. 2011

Mechanical Stiffness grades metastatic potential in patient tumor cells and in cancer cell lines.  71:5075-5080. 2011

The Mef/Elf4 transcription factor fine tunes the DNA damage response.  71:4857-4865. 2011

HOXC9 links cell-cycle exit and neuronal differentiation and is a prognostic marker in neuroblastoma.  71:4314-4324. 2011

An EGFR-ERK-SOX9 signaling cascade links urothelial development and regeneration to cancer.  71:3812-3821. 2011

Abstract 2262: The prognostic value of p53 abnormalities in colorectal cancers varies based on detection methods.  71:2262-2262. 2011

β2-microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bone metastasis in human cancer cells.  71:2600-2610. 2011

Identification of a tumor suppressor relay between the FOXP3 and the Hippo pathways in breast and prostate cancers.  71:2162-2171. 2011

miR-99 family of microRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation.  71:1313-1324. 2011

Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks.  71:614-624. 2011

P190RhoGEF (Rgnef) promotes colon carcinoma tumor progression via interaction with focal adhesion kinase.  71:360-370. 2011

NEDD8-targeting drug MLN4924 elicits DNA rereplication by stabilizing Cdt1 in S phase, triggering checkpoint activation, apoptosis, and senescence in cancer cells.  70:10310-10320. 2010

Homotypic gap junctional communication associated with metastasis suppression increases with PKA activity and is unaffected by PI3K inhibition.  70:10002-10011. 2010

Heparanase enhances local and systemic osteolysis in multiple myeloma by upregulating the expression and secretion of RANKL.  70:8329-8338. 2010

Targeting wild-type and mutant p53 with small molecule CP-31398 blocks the growth of rhabdomyosarcoma by inducing reactive oxygen species-dependent apoptosis.  70:6566-6576. 2010

DNA damage-induced cytotoxicity is dissociated from BRCA1's DNA repair function but is dependent on its cytosolic accumulation.  70:6258-6267. 2010

Piracy of prostaglandin E2/EP receptor-mediated signaling by Kaposi's sarcoma-associated herpes virus (HHV-8) for latency gene expression: strategy of a successful pathogen..  70:3697-3708. 2010

Abstract 2827: Adolescent diet and serum hormones, breast density and bone mineral density in young adults: findings from the Dietary Intervention in Children (DISC) Follow-Up Study.  70:2827-2827. 2010

Smad signaling is required to maintain epigenetic silencing during breast cancer progression.  70:968-978. 2010

Characterization of phosphoglycerate kinase-1 expression of stromal cells derived from tumor microenvironment in prostate cancer progression.  70:471-480. 2010

Epithelial-to-mesenchymal transition and ovarian tumor progression induced by tissue transglutaminase.  69:9192-9201. 2009

Upregulation of neutrophil gelatinase-associated lipocalin by ErbB2 through nuclear factor-kappaB activation..  69:9163-9168. 2009

Correction: Glomus tumors in neurofibromatosis type 1: Genetic, functional, and clinical evidence of a novel association (Cancer Research (2009) 69, (7393-7401)).  69:8216. 2009

Glomus tumors in neurofibromatosis type 1: Genetic, functional, and clinical evidence of a novel association.  69:7393-7401. 2009

Metastamir: The field of metastasis-regulatory microRNA is spreading.  69:7495-7498. 2009

Plasminogen kringle 5 induces apoptosis of brain microvessel endothelial cells: Sensitization by radiation and requirement for GRP78 and LRP1.  69:5537-5545. 2009

β1 integrin cytoplasmic variants differentially regulate expression of the antiangiogenic extracellular matrix protein thrombospondin 1.  69:5374-5382. 2009

Cyclophosphamide augments antitumor immunity: Studies in an autochthonous prostate cancer model.  69:4309-4318. 2009

Tumor-Infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-Arginine metabolism.  69:3086-3094. 2009

Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein-1 transcriptional activity.  69:2540-2549. 2009

F0XP3 Up-regulates p21 expression by site-specific inhibition of histone deacetylase 2/histone deacetylase 4 association to the locus.  69:2252-2259. 2009

Breast cancer metastasis suppressor 1 up-regulates miR-146, Which suppresses breast cancer metastasis.  69:1279-1283. 2009

Vasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis through a CD36-dependent mechanism.  69:1212-1220. 2009

Effects of methyl derivatives of the rexinoid UAB30 on methyinitrosourea (MNU) induced mammary cancers and on various indicators of toxicity..  69:138S-138S. 2009

Approaches to complex pathways in molecular epidemiology: Summary of a special conference of the american association for cancer research.  68:10028-10030. 2008

CXCR6 induces prostate cancer progression by the AKT/mammalian target of rapamycin signaling pathway.  68:10367-10376. 2008

Effects of dasatinib on Src kinase activity and downstream intracellular signaling in primitive chronic myelogenous leukemia hematopoietic cells.  68:9624-9633. 2008

Erlotinib attenuates homologous recombinational repair of chromosomal breaks in human breast cancer cells.  68:9141-9146. 2008

EWS-FLI1 induces developmental abnormalities and accelerates sarcoma formation in a transgenic mouse model.  68:8968-8975. 2008

A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer PC3 cells in vitro and in vivo: Involvement of nuclear factor-κB signaling.  68:8564-8572. 2008

A novel dietary flavonoid fisetin inhibits androgen receptor signaling and tumor growth in athymic nude mice.  68:8555-8563. 2008

Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenograftsby diffusion-weighted magnetic resonance imaging.  68:8369-8376. 2008

Bone marrow X kinase-mediated signal transduction in irradiated vascular endothelium (Cancer Research (2008) 68, (2861-2869)).  68:8189. 2008

Regulation of estrogenic effects by beclin 1 in breast cancer cells.  68:7855-7863. 2008

A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: Identification of DDX5-ETV4 fusion protein in prostate cancer.  68:7629-7637. 2008

Mechanism of in vitro pancreatic cancer cell growth inhibition by melanoma differentiation-associated gene-7/interleukin-24 and perillyl alcohol.  68:7439-7447. 2008

BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization.  68:6953-6962. 2008

Suppression of inhibitor of differentiation 2, a target of mutant p53, is required for gain-of-function mutations.  68:6789-6796. 2008

Targeting cancer stem cells through L1CAM suppresses glioma growth.  68:6043-6048. 2008

Vascular endothelial growth factor reduces tamoxifen efficacy and promotes metastatic colonization and desmoplasia in breast tumors.  68:6232-6240. 2008

Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients.  68:5869-5877. 2008

RAP80 responds to DNA damage induced by both ionizing radiation and UV irradiation and is phosphorylated at Ser²⁰⁵.  68:4269-4276. 2008

Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice.  68:4340-4346. 2008

Antagonistic roles of CD4⁺ and CD8⁺ T-cells in 7,12-dimethylbenz(a)anthracene cutaneous carcinogenesis.  68:3924-3930. 2008

Bone marrow X kinase-mediated signal transduction in irradiated vascular endothelium.  68:2861-2869. 2008

Identification of p18^INK4c as a tumor suppressor gene in glioblastoma multiforme.  68:2564-2569. 2008

Protective role of Toll-like receptor 4 during the initiation stage of cutaneous chemical carcinogenesis (Cancer Research (2008) 68, (615-622)).  68:1609. 2008

Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14.  68:1012-1021. 2008

Tristetraprolin down-regulates interleukin-8 and vascular endothelial growth factor in malignant glioma cells.  68:674-682. 2008

Cannabinoids for cancer treatment: Progress and promise.  68:339-342. 2008

Protective role of toll-like receptor 4 during the initiation stage of cutaneous chemical carcinogenesis.  68:615-622. 2008

Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer.  68:73-80. 2008

Paxillin is a target for somatic mutations in lung cancer: Implications for cell growth and invasion.  68:132-142. 2008

Aurora-A kinase regulates breast cancer-associated gene 1 inhibition of centrosome-dependent microtubule nucleation.  67:11186-11194. 2007

Cks1 regulates cdk1 expression: A novel role during mitotic entry in breast cancer cells.  67:11393-11401. 2007

A polycomb repression signature in metastatic prostate cancer predicts cancer outcome.  67:10657-10663. 2007

Genetic determinants of mitochondrial response to arsenic in yeast Saccharomyces cerevisiae.  67:9740-9749. 2007

Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70.  67:9407-9416. 2007

Erratum: SIRT1 is significantly elevated in mouse and human prostate cancer (Cancer Research (2007) 67, (6612-6618)).  67:8423. 2007

Erratum: Targeted cancer gene therapy using a hypoxia inducible factor-dependent oncolytic adenovirus armed with interleukin-4 (Cancer Research (2007) 67, (6872-6881)).  67:8422-8423. 2007

Inactivation of Smad4 accelerates Kras^G12D-mediated pancreatic neoplasia.  67:8121-8130. 2007

Farnesol-induced apoptosis in human lung carcinoma cells is coupled to the endoplasmic reticulum stress response.  67:7929-7936. 2007

A growth hormone receptor mutation impairs growth hormone autofeedback signaling in pituitary tumors.  67:7505-7511. 2007

Enhanced peritoneal ovarian tumor dissemination by tissue transglutaminase.  67:7194-7202. 2007

BCR-tyrosine 177 plays an essential role in Ras and Akt activation and in human hematopoietic progenitor transformation in chronic myelogenous leukemia.  67:7045-7053. 2007

Proteomics-based identification of proteins secreted in apical surface fluid of squamous metaplastic human tracheobronchial epithelial cells cultured by three-dimensional organotypic air-liquid interface method.  67:6565-6573. 2007

SIRT1 is significantly elevated in mouse and human prostate cancer.  67:6612-6618. 2007

Targeted cancer gene therapy using a hypoxia inducible factor-dependent oncolytic adenovirus armed with interleukin-4.  67:6872-6881. 2007

The ubiquitin-interacting motif-containing protein RAP80 interacts with BRCA1 and functions in DNA damage repair response.  67:6647-6656. 2007

Alterations of the HBP1 transcriptional repressor are associated with invasive breast cancer.  67:6136-6145. 2007

Effects of sustained antiangiogenic therapy in multistage prostate cancer in TRAMP ,model.  67:5789-5797. 2007

HIV protease inhibitors enhance the efficacy of irradiation.  67:4886-4893. 2007

Interleukin-12 deficiency is permissive for angiogenesis in UV radiation-induced skin tumors.  67:3785-3793. 2007

Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma.  67:3461-3467. 2007

Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice.  67:3475-3482. 2007

Inactivation of Apc in the mouse prostate causes prostate carcinoma.  67:2490-2496. 2007

Sensitization of mesothelioma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by heat stress via the inhibition of the 3-phosphoinositide-dependent kinase 1/Akt pathway.  67:2865-2871. 2007

Smad4 regulates claudin-1 expression in a transforming growth factor-β-independent manner in colon cancer cells.  67:1571-1579. 2007

Growth factor stimulation reduces residual quiescent chronic myelogenous leukemia progenitors remaining after imatinib treatment.  67:1113-1120. 2007

A glycolytic mechanism regulating an angiogenic switch in prostate cancer.  67:149-159. 2007

Cancer progression in the transgenic adenocarcinoma of mouse prostate mouse is related to energy balance, body mass, and body composition, but not food intake.  67:417-424. 2007

Tumor-targeted enzyme/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma.  67:22-25. 2007

Antitumor effect of 2-methoxyestradiol in a rat orthotopic brain tumor model.  66:11991-11997. 2006

Ataxia telangiectasia mutated down-regulates phospho-extracellular signal-regulated kinase 1/2 via activation of MKP-1 in response to radiation.  66:11554-11559. 2006

Oncogenic serine-threonine kinase receptor-associated protein modulates the function of ewing sarcoma protein through a novel mechanism.  66:10824-10832. 2006

β2-microglobulin is a signaling and growth-promoting factor for human prostate cancer bone metastasis.  66:9108-9116. 2006

AAL881, a novel small molecule inhibitor of RAF and vascular endothelial growth factor receptor activities, blocks the growth of malignant glioma.  66:8722-8730. 2006

Inducible resistance of tumor cells to tumor necrosis factor-related apoptosis-inducing ligand receptor 2-mediated apoptosis by generation of a blockade at the death domain function.  66:8520-8528. 2006

Mechanism of action of sulforaphane: Inhibition of p38 mitogen-activated protein kinase isoforms contributing to the induction of antioxidant response element-mediated heme oxygenase-1 in human hepatoma HepG2 cells.  66:8804-8813. 2006

BiP/GRP78 is an intracellular target for MDA-7/IL-24 induction of cancer-specific apoptosis.  66:8182-8191. 2006

Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor.  66:7843-7848. 2006

Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms.  66:7067-7074. 2006

Papilloma development is delayed in osteopontin-null mice: Implicating an antiapoptosis role for osteopontin.  66:7119-7127. 2006

The primary cilium in cell signaling and cancer.  66:6463-6467. 2006

Oncogenic function of a novel WD-domain protein, STRAP, in human carcinogenesis.  66:6156-6166. 2006

A systems approach to model metastatic progression.  66:5537-5539. 2006

(-)-Epigallocatechin-3-gallate prevents photocarcinogenesis in mice through interleukin-12-dependent DNA repair.  66:5512-5520. 2006

Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.  66:2500-2505. 2006

Molecular target-based therapy of pancreatic cancer.  66:2403-2413. 2006

Erratum: Promotion of invasion and metastatic potential by Bcl-2 (Cancer Research (July 1, 2005) 65 (5554-5560)).  66:1250. 2006

Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis.  65:11259-11264. 2005

Loss of phosphatase and tensin homologue increases transforming growth factor β-mediated invasion with enhanced SMAD3 transcriptional activity.  65:11276-11281. 2005

Erratum: Activator protein 2α status determines the chemosensitivity of cancer cells: Implications in cancer chemotherapy (Cancer Research (October 1, 2005) 65 (8628-8634)).  65:11228. 2005

Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and proteomic analyses.  65:10214-10222. 2005

Protein transduction of dendritic cells for NY-ESO-1-based immunotherapy of myeloma.  65:10041-10049. 2005

Activator protein 2α status determines the chemosensitivity of cancer cells: Implications in cancer chemotherapy.  65:8628-8634. 2005

Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas.  65:8679-8689. 2005

The bisphosphonate YM529 inhibits osteolytic and osteoblastic changes and CXCR-4-induced invasion in prostate cancer.  65:8818-8825. 2005

The distal zinc finger domain of AML1/MDS1/EVI1 is an oligomerization domain involved in induction of hematopoietic differentiation defects in primary cells in vitro.  65:7603-7611. 2005

Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasis.  65:7370-7377. 2005

β1A integrin expression is required for type 1 insulin-like growth factor receptor mitogenic and transforming activities and localization to focal contacts.  65:6692-6700. 2005

Bcl-2 promotes invasion and lung metastasis by inducing matrix metalloproteinase-2.  65:5554-5560. 2005

Distinct B-cell and T-cell lymphoproliferative disease prevalence among dog breeds indicates heritable risk.  65:5654-5661. 2005

Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases.  65:5778-5784. 2005

Lyn kinase activity is the predominant cellular Src kinase activity in glioblastoma tumor cells.  65:5535-5543. 2005

Hypersialylation of β 1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility.  65:4645-4652. 2005

The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling.  65:4789-4798. 2005

High-resolution genome-wide mapping of genetic alterations in human glial brain tumors.  65:4088-4096. 2005

Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-κB activity.  65:3586-3595. 2005

Mouse models of subcutaneous spleen reservoir for multiple portal venous injections to treat liver malignancies.  65:3823-3827. 2005

Overexpression of cytochrome P450 1A1 and its novel spliced variant in ovarian cancer cells: Alternative subcellular enzyme compartmentation may contribute to carcinogenesis.  65:3726-3734. 2005

Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva).  65:3328-3335. 2005

Mitochondrial damage mediates genotoxicity of arsenic in mammalian cells.  65:3236-3242. 2005

Cannabinoid receptor as a novel target for the treatment of prostate cancer.  65:1635-1641. 2005

PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma.  65:1406-1413. 2005

Metastasis suppression by breast cancer metastasis suppressor 1 involves reduction of phosphoinositide signaling in MDA-MB-435 breast carcinoma cells.  65:713-717. 2005

Polymorphisms in genes related to oxidative stress (MPO, MnSOD, CAT) and survival after treatment for breast cancer.  65:1105-1111. 2005

Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway.  65:605-612. 2005

Androgen-independent prostate cancer is a heterogeneous group of diseases: Lessons from a rapid autopsy program.  64:9209-9216. 2004

Folate is associated with the natural history of high-risk human papillomaviruses.  64:8788-8793. 2004

Inhibition of smoothened signaling prevents ultraviolet B-induced basal cell carcinomas through regulation of fas expression and apoptosis.  64:7545-7552. 2004

Growth factor independence-1 is expressed in primary human neuroendocrine lung carcinomas and mediates the differentiation of murine pulmonary neuroendocrine cells.  64:6874-6882. 2004

JAGGED1 expression is associated with prostate cancer metastasis and recurrence.  64:6854-6857. 2004

Excellent in vivo bystander activity of fludarabine phosphate against human glioma xenografts that express the Escherichia coli purine nucleoside phosphorylase gene.  64:6610-6615. 2004

Effect of mutational inactivation of tyrosine kinase activity on BCR/ABL-induced abnormalities in cell growth and adhesion in human hematopoietic progenitors.  64:5322-5331. 2004

Fidelity of Runx2 activity in breast cancer cells is required for the generation of metastases-associated osteolytic disease.  64:4506-4513. 2004

Topical tazarotene chemoprevention reduces basal cell carcinoma number and size and Ptch1+/- mice exposed to ultraviolet or ionizing radiation.  64:4385-4389. 2004

Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4.  64:4302-4308. 2004

Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer.  64:3814-3822. 2004

Selectivity of an Oncolytic Herpes Simplex Virus for Cells Expressing the DF3/MUC1 Antigen.  64:2561-2567. 2004

Adeno-Associated Virus 2-Mediated Antiangiogenic Cancer Gene Therapy: Long-Term Efficacy of a Vector Encoding Angiostatin and Endostatin over Vectors Encoding a Single Factor.  64:1781-1787. 2004

Pseudopalisades in Glioblastoma Are Hypoxic, Express Extracellular Matrix Proteases, and Are Formed by an Actively Migrating Cell Population.  64:920-927. 2004

The Role of Metastasis-Associated Protein 1 in Prostate Cancer Progression.  64:825-829. 2004

Vascular Endothelial Growth Factor Contributes to the Prostate Cancer-Induced Osteoblast Differentiation Mediated by Bone Morphogenetic Protein.  64:994-999. 2004

High Heparanase Activity in Multiple Myeloma Is Associated with Elevated Microvessel Density.  63:8749-8756. 2003

Inactivation of Wild-Type p53 Protein Function by Reactive Oxygen and Nitrogen Species in Malignant Glioma Cells.  63:8670-8673. 2003

Switching Mechanisms of Cell Death in mdm2- and mdm4-null Mice by Deletion of p53 Downstream Targets.  63:8664-8669. 2003

Overexpression of the Oncogenic Kinase Pim-1 Leads to Genomic Instability.  63:8079-8084. 2003

Tumor necrosis factor α induces angiogenic factor up-regulation in malignant glioma cells: A role for RNA stabilization and HuR.  63:4181-4187. 2003

Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells.  63:2631-2637. 2003

Transforming growth factor β inhibits the antigen-presenting functions and antitumor activity of dendritic cell vaccines.  63:1860-1864. 2003

Modulation of coxsackie-adenovirus receptor expression for increased adenoviral transgene expression.  63:847-853. 2003

Melanoma metastasis suppression by chromosome 6: Evidence for a pathway regulated by CRSP3 and TXNIP.  63:432-440. 2003

Comparative gene expression profile analysis of GLI and c-MYC in an epithelial model of malignant transformation.  62:5867-5873. 2002

Promotion of malignant astrocytoma cell migration by osteopontin expressed in the normal brain: Differences in integrin signaling during cell adhesion to osteopontin versus vitronectin.  62:5336-5343. 2002

Neoglycans, carbodiimide-modified glycosaminoglycans: A new class of anticancer agents that inhibit cancer cell proliferation and induce apoptosis.  62:3722-3728. 2002

Human cytomegalovirus infection and expression in human malignant glioma.  62:3347-3350. 2002

Initiation of human astrocytoma by clonal evolution of cells with progressive loss of p53 functions in a patient with a 283H TP53 germ-line mutation: Evidence for a precursor lesion.  62:2897-2905. 2002

Geldanamycin induces degradation of hypoxia-inducible factor 1α protein via the proteosome pathway in prostate cancer cells.  62:2478-2482. 2002

Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone.  62:1832-1837. 2002

Aberrant splicing in several human tumors in the tumor suppressor genes neurofibromatosis type 1, neurofibromatosis type 2, and tuberous sclerosis 2.  62:1503-1509. 2002

Overexpression of thrombospondin-1 reduces growth and vascular index but not perfusion in glioblastoma.  62:1191-1195. 2002

High incidence of T-cell lymphomas in mice deficient in the retinoid-related orphan receptor RORγ.  62:901-909. 2002

Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas.  62:773-780. 2002

Predisposition to efficient mammary tumor metastatic progression is linked to the breast cancer metastasis suppressor gene Brms1.  61:8866-8872. 2001

RNA replicons derived from poliovirus are directly oncolytic for human tumor cells of diverse origins.  61:8470-8479. 2001

Profiling of cancer cells using protein microarrays: Discovery of novel radiation-regulated proteins.  61:7585-7593. 2001

Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: A cancer and leukemia group B study.  61:7233-7239. 2001

Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP).  61:6777-6782. 2001

Adeno-associated virus for cancer gene therapy.  61:6313-6321. 2001

Targeting oncolytic adenoviral agents to the epidermal growth factor pathway with a secretory fusion molecule.  61:6377-6381. 2001

Tetrasomy is induced by human papillomavirus type 18 e7 gene expression in keratinocyte raft cultures.  61:4858-4863. 2001

Fas-induced expression of chemokines in human glioma cells: Involvement of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase.  61:3084-3091. 2001

Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication.  61:1765-1767. 2001

HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3′ untranslated regions of cytokine and angiogenic factor mRNAs.  61:2154-2161. 2001

Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells.  61:1162-1170. 2001

Increase of GKLF messenger RNA and protein expression during progression of breast cancer.  60:6488-6495. 2000

Midkine promoter-based adenoviral vector gene delivery for pediatric solid tumors.  60:4305-4310. 2000

Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13.  60:2764-2769. 2000

Gene transfer into brain parenchyma elicits antitumor effects.  60:1797-1799. 2000

Transfection of constitutively active mitogen-activated protein/extracellular signal-regulated kinase kinase confers tumorigenic and metastatic potentials to NIH3T3 cells.  60:1552-1556. 2000

Identification of the putative brain tumor antigen BF7/GE2 as the (De)toxifying enzyme microsomal epoxide hydrolase.  60:1403-1409. 2000

The CCAAT displacement protein/cut homeodomain protein represses osteocalcin gene transcription and forms complexes with the retinoblastoma protein-related protein p107 and cyclin A.  59:5980-5988. 1999

The PTEN lipid phosphatase domain is not required to inhibit invasion of glioma cells.  59:5479-5482. 1999

Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line.  59:4559-4563. 1999

Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis.  59:3855-3860. 1999

Protein kinase C δ involvement in mammary tumor cell metastasis.  59:3230-3238. 1999

Genetic and functional analyses exclude mortality factor 4 (MORF4) as a keratinocyte senescence gene.  59:2038-2040. 1999

Replication-competent, nonneuroinvasive genetically engineered herpes virus is highly effective in the treatment of therapy-resistant experimental human tumors.  59:2055-2058. 1999

Interleukin 8: An autocrine growth factor for malignant mesothelioma.  59:367-371. 1999

Differential susceptibility of primary and established human glioma cells to adenovirus infection: Targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer.  58:5738-5748. 1998

Selective killing of glioma cell lines using an astrocyte-specific expression of the herpes simplex virus-thymidine kinase gene.  58:4577-4580. 1998

Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.  58:4173-4179. 1998

Intracellular expression of a single-chain antibody directed against human papillomavirus type 16 E7 oncoprotein achieves targeted antineoplastic effects.  58:1893-1900. 1998

Molecular mimicry of carcinoembryonic antigen by peptides derived from the structure of an anti-idiotype antibody.  58:1217-1224. 1998

Plasma tocopherol and prevalence of colorectal adenomas in a multiethnic population.  58:661-666. 1998

Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.  57:4325-4332. 1997

CaN19 expression in benign and malignant hyperplasias of the skin and oral mucosa: Evidence for a role in regenerative differentiation.  57:3055-3062. 1997

Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1.  57:2384-2387. 1997

Endometrial hyperplasia and apoptosis following neonatal diethylstilbestrol exposure and subsequent estrogen stimulation in both host and transplanted hamster uteri.  57:1903-1908. 1997

Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors.  57:1502-1509. 1997

Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor.  57:1447-1451. 1997

The cell cycle inhibitor p27 is an independent prognostic marker in small (T(1a,b)) invasive breast carcinomas.  57:1259-1263. 1997

Mitochondrial genome damage associated with cigarette smoking.  56:5692-5697. 1996

Expression of cell cycle-regulated proteins in prostate cancer.  56:4159-4163. 1996

Suppression of MDA-MB-435 breast carcinoma cell metastasis following the introduction of human chromosome 11.  56:1222-1227. 1996

Correspondence re: G. P. Studzinski and D. C. Moore, Sunlight - Can it prevent as well as cause cancer? Cancer Res., 55: 4014-4022, 1995.  56:925. 1996

Experimental approaches to increase radiolabeled antibody localization in tumors.  55. 1995

Experimental approaches to increase radiolabeled antibody localization in tumors..  55:5729s-5732s. 1995

Fractionated radioimmumotherapy of human colon carcinoma xenografts with¹³¹I-labeled monoclonal antibody CC49.  55. 1995

Prognostic factors for radioimmunotherapy in patients with B-lymphocytic malignancies.  55. 1995

Prognostic factors for radioimmunotherapy in patients with B-lymphocytic malignancies..  55:5893s-5898s. 1995

Reconciliation of tumor dose response to external beam radiotherapy versus radioimmunotherapy with ¹³¹iodine-labeled antibody for a colon cancer model.  55. 1995

Yttrium-90 chimeric L6 therapy of human breast cancer in nude mice and apoptosis-related messenger RNA expression.  55. 1995

Yttrium-90 chimeric L6 therapy of human breast cancer in nude mice and apoptosis-related messenger RNA expression..  55:5837s-5841s. 1995

Chromosome Band 11q23 Translocation Breakpoints Are DNA Topoisomerase II Cleavage Sites.  55:4287-4292. 1995

Phase II Trial of Murine Monoclonal Antibody D612 Combined with Recombinant Human Monocyte Colony-stimulating Factor (rhM-CSF) in Patients with Metastatic Gastrointestinal Cancer.  55:4339-4346. 1995

Expression of a Deletion Mutant of the E2F1 Transcription Factor in Fibroblasts Lengthens S Phase and Increases Sensitivity to S Phase-specific Toxins.  55:2883-2891. 1995

Neoplastic Reversion Accomplished by High Efficiency Adenoviral-mediated Delivery of an Anti-ras Ribozyme.  55:2024-2028. 1995

Enhancement of 5-Fluoro-2′-deoxyuridine Antitumor Efficacy by the Uridine Phosphorylase Inhibitor 5-(Benzyloxybenzyl)barbituric Acid Acyclonucleoside.  55:1092-1098. 1995

Reactive oxygen species in tumorigenesis..  54:1890s-1894s. 1994

Analysis of the p53 Gene and Its Expression in Human Glioblastoma Cells.  54:649-652. 1994

Bcl-2 Inhibits T-Cell-mediated Cytolysis of a Leukemia Cell Line.  54:4851-4854. 1994

Characterization of Poliovirus Replicons Encoding Carcinoembryonic Antigen.  54:6359-6364. 1994

Is Tumor Cell Radiation Resistance Correlated with Metastatic Ability?.  54:1736-1741. 1994

Potentiation of 5-Fluorouracil Efficacy by the Dihydrouracil Dehydrogenase Inhibitor, 5-Benzyloxybenzyluracil.  54:5166-5170. 1994

A Phase I Clinical Trial of Murine Monoclonal Antibody D612 in Patients with Metastatic Gastrointestinal Cancer.  53:4555-4562. 1993

In vivo administration of the anticancer agent bryostatin 1 activates platelets and neutrophils and modulates protein kinase C activity..  53:2810-2815. 1993

Turcot's Syndrome of Glioma and Polyposis Occurs in the Absence of Germ Line Mutations of Exons 5 to 9 of the p53 Gene.  53:957-961. 1993

Differences in Activities and Substrate Specificity of Human and Murine Pyrimidine Nucleoside Phosphorylases: Implications for Chemotherapy with 5-Fluoropyrimidines.  53:3687-3693. 1993

Expression of Sulfated Glycoprotein 2 Is Associated with Carcinogenesis Induced by A^Nitroso-AT-methylurea in Rat Prostate and Seminal Vesicle.  53:1480-1483. 1993

Mutation of the Ki-ras Protooncogene in Human Endometrial Hyperplasia and Carcinoma.  53:1906-1910. 1993

Variant CD44 Adhesion Molecules Are Expressed in Human Brain Metastases but not in Glioblastomas.  53:5345-5349. 1993

la,25-Dihydroxyvitamin D3 Enhances 12-0-Tetradecanoylphorbol-13-acetate-induced Tumorigenic Transformation and Osteopontin Expression in Mouse JB6 Epidermal Cells1.  53:2217-2220. 1993

An Altered 11-Kilobase Transcript in Leukemic Cell Lines with the t(4;11)(q21;q23) chromosome translocation.  52:3811-3813. 1992

Characterization of the PML-RARa Chimeric Product of the Acute Promyelocytic Leukemia-specific t(15;17) Translocation.  52:3687-3692. 1992

Effect of Systemic Hyperinsulinemia in Cancer Patients.  52:3845-3850. 1992

Expression of High-Affinity Laminin Receptor mRNA Correlates with Cell Proliferation Rather Than Invasion in Human Papillomavirus-associated Cervical Neoplasms.  52:1561-1567. 1992

Immunogenetic Influences on the Initiation Stage of the Cutaneous Chemical Carcinogenesis Pathway.  52:6106-6109. 1992

Improved Delivery of Radiolabeled Anti-Bl Monoclonal Antibody to Raji Lymphoma Xenografts by Predosing with Unlabeled Anti-Bl Monoclonal Antibody.  52:637-642. 1992

In Vivo Administration of Bryostatin 1, a Protein Kinase C Activator, Decreases Murine Resistance to Salmonella typhimurium.  52:2143-2147. 1992

Interleukin-8 Is Produced in Neoplastic and Infectious Diseases of the Human Central Nervous System.  52:4297-4305. 1992

Phase I Trial of the Murine Monoclonal Anti-GD2 Antibody 14G2a in Metastatic Melanoma.  52:4342-4347. 1992

Retinoid Antagonism of Estrogen-responsive Transforming Growth Factor a and pS2 Gene Expression in Breast Carcinoma Cells.  52:3938-3945. 1992

Therapy with Unlabeled and 131I-labeled Pan-B-Cell Monoclonal Antibodies in Nude Mice Bearing Raji Burkitt's Lymphoma Xenografts.  52:6476-6481. 1992

Pharmacokinetics and Immune Response of 131I-ChimericMouse/Human B72.3 (Human 74) Monoclonal Antibody in Humans.  51:5461-5466. 1991

Evidence for the Elevation of Serum Carcinoembryonic Antigen and Tumor-associated Glycoprotein-72 Levels in Patients Administered Interferons.  51:4155-4163. 1991

1α,25-Dihydroxyvitamin D3 Stimulates Synthesis and Secretion of Nonphosphorylated Osteopontin (Secreted Phosphoprotein 1) in Mouse JB6 Epidermal Cells.  51:2144-2150. 1991

Radiotherapy in Mice with Yttrium-90-labeled Anti-Ly1 Monoclonal Antibody: Therapy of Established Graft-versus-Host Disease Induced across the Major Histocompatibility Barrier.  51:1891-1897. 1991

Radiotherapy in Mice with Yttrium-90-labeled Anti-Ly1 Monoclonal Antibody: Therapy of the T Cell Lymphoma EL4.  51:1883-1890. 1991

Coexpression of Different Antigenic Markers on Moieties That Bear CA 125 Determinants.  51:468-475. 1991

Photodynamic Therapy Induces Rapid Cell Death by Apoptosis in LSI78Y Mouse Lymphoma Cells.  51:5993-5996. 1991

Human Glioblastoma Cells Release Interleukin 6 in Vivo and in Vitro.  50:6683-6688. 1990

Conditioning: A New Approach to Immunotherapy.  50:4295-4299. 1990

Amplification of the c-myc Gene in Human Medulloblastoma Cell Lines and Xenografts.  50:2347-2350. 1990

myc Gene Amplification and Expression in Primary Human Neuroblastoma.  50:1459-1463. 1990

Glycosphingolipids in Bomirski Transplantable Melanomas in Hamsters.  49:7051-7056. 1989

Effect of Dietary Tannic Acid on Epidermal, Lung, and Forestomach Polycyclic Aromatic Hydrocarbon Metabolism and Tumorigenicity in Sencar Mice.  49:5784-5788. 1989

Effects of Bryostatins and Retinoic Acid on Phorbol Ester- and Diacylglycerol-induced Squamous Differentiation in Human Tracheobronchial Epithelial Cells.  49:3990-3995. 1989

Expression of Human DNA Topoisomerase I in Yeast Cells Lacking Yeast DNA Topoisomerase I: Restoration of Sensitivity of the Cells to the Antitumor Drug Camptothecin.  49:6318-6323. 1989

Cytotoxic effects of anti-cd5 radioimmunotoxins on human tumors in vitro and in a nude mouse model.  48:7107-7114. 1988

Development and Characterization of a Rat Model for Locally Recurring Mammary Tumors: Sensitivities to 5-Fluoro-2’-deoxyuridine, Adriamycin, and X-Irradiation.  48:4549-4554. 1988

Cholesterol Sulfate Accumulation in Tumorigenic and Nontumorigenic Rat Esophageal Epithelial Cells: Evidence for Defective Differentiation Control in Tumorigenic Cells.  48:5289-5295. 1988

Formation of Conjugates of 2-Fluoro-β-alanine and Bile Acids during the Metabolism of 5-Fluorouracil and 5-Fluoro-2-deoxyuridine in the Isolated Perfused Rat Liver.  48:2010-2014. 1988

Growth of Rat Mammary Adenocarcinoma Cells in Semisolid Clonogenic Medium Not Correlated with Spontaneous Metastatic Behavior: Heterogeneity in the Metastatic, Antigenic, Enzymatic, and Drug Sensitivity Properties of Cells from Different Sized Colonies.  48:399-404. 1988

Localization and Imaging of Radiolabeled Monoclonal Antibodies Against Colorectal Carcinoma in Tumor-Bearing Nude Mice.  48:4256-4260. 1988

Localization and Imaging with Radioiodine-labeled Monoclonal Antibodies in a Xenogeneic Tumor Model for Human B-Cell Lymphoma.  48:2475-2482. 1988

Localization and imaging of radiolabeled monoclonal antibodies against colorectal carcinoma in tumor-bearing nude mice.  48:4324-4333. 1988

Properties of L1210 Cells Resistant to α-Difluoro Methyl Or Nithine.  48:2678-2682. 1988

Flow Cytometric Analysis of Human Uterine Sarcomas and Cell Lines.  47:2814-2820. 1987

Degradation of Basement Membrane Type IV Collagen and Lung Subendothelial Matrix by Rat Mammary Adenocarcinoma Cell Clones of Differing Metastatic Potentials.  47:4869-4876. 1987

Induction of Contact Hypersensitivity to Dimethylbenz(a)anthracene and Benzo(a)pyrene in C3N/HeN Mice1.  47:6074-6078. 1987

New Benzoic Acid Derivatives with Retinoid Activity: Lack of Direct Correlation between Biological Activity and Binding to Cellular Retinoic Acid Binding Protein.  47:3523-3527. 1987

Amplification and Rearrangement of DNA Sequences from the Chromosomal Region 2p24 in Human Neuroblastomas.  46:5297-5301. 1986

Immunological suppression in mice treated with hematoporphyrin derivative photoradiation..  46:1608-1611. 1986

In Vitro Effect of Monoclonal Anti-ldiotype Antibodies (Anti-M104E) on MOPC 104E Myeloma Cells.  46:1250-1254. 1986

Invasiveness and Metastatic Capability of Rat Fibroblast-like Cells before and after Transfection with Immortalizing and Transforming Genes.  46:4787-4795. 1986

Enzymes off Uracil Catabolism in Normal and Neoplastic Human Tissues.  45:5405-5412. 1985

Heterogeneity and Prognostic Significance off Macrophages in Human Colonic Carcinomas.  45:5196-5200. 1985

Control of Polyomavirus T-Antigen and DNA Synthesis in Mouse Embryo Fibroblast Cells by Vitamin A.  45:2098-2102. 1985

Enzyme Activities in Prostatic Carcinoma Related to Gleason Grades.  45:442-446. 1985

Local hyperthermia with interstitial techniques..  44:4752s-4756s. 1984

Inhibition of Nucleoside Transport in Murine Lymphoma L5178Y Cells and Human Erythrocytes by the Uridine Phosphorylase Inhibitors 5-Benzylacyclouridine and 5-Benzyloxybenzylacyclouridine.  44:3744-3748. 1984

Potentiation of 5-Fluoro-2'-deoxyuridine Antineoplastic Activity by the Uridine Phosphorylase Inhibitors Benzylacyclouridine and Benzyloxybenzylacyclouridine.  44:1852-1856. 1984

Reduction of Tumor Burden in a Murine Osteosarcoma following Hyperthermia Combined with Cyclophosphamide.  44:1405-1408. 1984

Loss of High-Energy Phosphate following Hyperthermia Demonstrated by in Vivo 31P-Nuclear Magnetic Resonance Spectroscopy.  44:633-638. 1984

Local hyperthermia with interstitial techniques.  44. 1984

Nonrandom Escape of Tumor Cells from Immune Lysis Due to Intraclonal Fluctuations in Antigen Expression.  43:4050-4056. 1983

Eosinophil infiltration of human colonic carcinomas as a prognostic indicator.  43:2997-3000. 1983

Action of epidermal growth factor and retinoids on anchorage-dependent and-independent growth of nontransformed rat kidney cells.  43:2094-2099. 1983

MOPC 104E Plasmacytoma functional heterogeneity and maturational potential in culture.  43:953-958. 1983

Tumor proliferation and chemotherapy in immunosuppressed mice.  43:1097-1100. 1983

Action of Retinoids on the Anchorage-independent Growth of Normal Rat Kidney Fibroblasts Induced by 12- O-Tetradecanoylphorbol-13-acetate or Sarcoma Growth Factor.  43:68-72. 1983

Heterogeneous response and clonal drift of sensitivities of metastatic 13762nf mammary adenocarcinoma clones to ϒ-radiation in vitro.  43:6-10. 1983

Increase of hla-dr4 in melanoma patients from.  42:4276-4279. 1982

Prostatic hexosaminidase activity in patients wi hyoerplasia and prostatic carcinoma.  42:4300-4303. 1982

Inhibitory Effect of L-Homoarginine on Murine Osteosarcoma cell proliferation.  42:1072-1077. 1982

Effect of Plasminogen Activator (Urokinase), Piasmin, and Thrombin on Glycoprotein and Collagenous Components of Basement Membrane.  41:4629-4636. 1981

Urinary Glycosaminoglycan Excretion as a Biochemical Marker in Patients with Bladder Carcinoma.  41:3868-3873. 1981

Effect of Immune Response to Sheep Red Blood Cells on Plasmacytoma MOPC 104 E.  41:2197-2199. 1981

Maintenance of MOPC 104E Myeloma in Plateau Phase.  40:2372-2376. 1980

Relationship between Binding Affinities to Cellular Retinoic Acid-binding Protein and in Vivo and in Vitro Properties for 18 Retinoids.  40:212-220. 1980

Distribution of radiolabled alloantibodies in mice bearing 3-methylcholanthrene-induced sarcomas.  39:3363-3368. 1979

Comparative Tumor-initiating Activity of Methylated Benzo(a)pyrene Derivatives in Mouse Skin 1.  40:1073-1076. 1979

A methodological approach to the prediction of anticancer drug effect in humans.  39:402-407. 1979

Differences in the ability of human lymphoblastoid lines to exclude bromodeoxyuridine and in their sensitivity to methyl methanesulfonate and to incorporated [³h]thymidine.  39:312-320. 1979

Hematology and Clinical Chemistry Reference Values for C57BL/6 x DBA/2 F1Mice.  38:2636-2639. 1978

Cell cycle-specific oncogenic transformation of C3H/10T1/2 clone 8 mouse embryo cells by 1-beta-D-arabinofuranosylcytosine..  37:2214-2217. 1977

An Experimental Approach to Relate a Tumor-associated Enzyme Marker to Tumor Cell Numbers.  37:365-368. 1977

Cis-Dichlorodiammineplatinum(II) Chemotherapy in Experimental Murine Myeloma MOPC 104E.  37:771-774. 1977

Combination versus sequential five drug chemotherapy in metastatic carcinoma of the breast.  36. 1976

Separation of cells with histochemically demonstrable acid phosphatase activity from suspensions of cells from human prostatic carcinomas in an isokinetic gradient of Ficoll in tissue culture medium.  36. 1976

Separation of Cells with Histochemically Demonstrable Acid Phosphatase Activity from Suspensions of Cells from Human Prostatic Carcinomas in an lsokinetic Gradient of Ficoll in Tissue Culture Medium.  36:481-486. 1976

The Effect of 1-β-D-Arabinofuranosylcytosine on Cell Viability, DNA Synthesis, and Chromatid Breakage in Synchronized Hamster Fibrosarcoma Cells.  36:3789-3797. 1976

Evaluation of a Cooperative Group Human Myeloma Protocol Using the MOPC 104E Myeloma Model.  35:1309-1313. 1975

Chemotherapy and Rate of Kill of Tumor Cells in a Mouse Plasmacytoma.  34:1738-1742. 1974